Opinion | The Attack on an Alzheimer’s Drug

Photo: /Associated Press Public-health and media critics failed to stop federal approval of Aduhelm, Biogen’s new drug for Alzheimer’s. So now they’re mounting an assault on the drug’s cost to stop Medicare from paying for it. Their sudden and rare … Read more

Opinion | An Alzheimer’s Breakthrough, At Last

A Biogen researcher works on the development of the medication aducanumab in Cambridge, Mass. Photo: David A. White/Associated Press The Food and Drug Administration gave hope to millions of Americans suffering from Alzheimer’s disease on Monday by approving Biogen’s aducanumab, … Read more